Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction, and Histone Deacetylase Inhibitors Research.
Going Beyond Surface Physics: Interface Engineering of <scp>PTAA</scp> for Efficient p‐i‐n Perovskite Photovoltaics
Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with <i>FLT3‐ITD</i>: A multicenter phase 2 study
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia
Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the <scp>MONITOR</scp> model in a nationwide multicenter study
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data
Abstract CT041: The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial
KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Uterine Leiomyomas: Safety and Efficacy of US-guided Suprapubic Transvaginal Radiofrequency Ablation at 1-year Follow-up